About
POLARISqb is a US quantum biotechnology company founded in 2020 that applies quantum computing and quantum-inspired algorithms to accelerate drug discovery and development, using quantum molecular simulation and optimization techniques to identify novel drug candidates and optimize molecular properties more efficiently than classical computational methods, focusing on using quantum advantage for pharmaceutical applications including drug design, molecular modeling, and therapeutic target identification to reduce drug development timelines and costs.
Quantum Specifications
| Quantum Focus | software |
Backed By
Lakestar
Lightspeed Venture Partners
Quantum Coast Capital
Type One Ventures
Trumpf Venture
Gic Government Of Singapore Investment Corporation
Hercules Capital
Inven Capital
Frequently Asked Questions
POLARISqb is a US quantum biotechnology company founded in 2020 that applies quantum computing and quantum-inspired algorithms to accelerate drug discovery and development, using quantum molecular simulation and optimization techniques to identify novel drug candidates and optimize molecular properties more efficiently than classical computational methods, focusing on using quantum advantage for pharmaceutical applications including drug design, molecular modeling, and therapeutic target iden...
POLARISqb is headquartered in San Francisco, United States.
POLARISqb was founded in 2020.
POLARISqb operates in the following sectors: quantum applications.
